|
|
| | Lenvatinib Impurity 5 Basic information |
| Product Name: | Lenvatinib Impurity 5 | | Synonyms: | Levatinib impurity 10;Lenvatinib impurity 1 4/Lenvatinib N-Oxide/4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide 1-Oxide;6-carbamoyl-4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline 1-oxide;Lenvatinib Impurity M;6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-, 1-oxide;6-Carbamoyl-4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline 1-oXnde;Lenvatinib N-Oxide;Lenvatinib N-Oxide/4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide 1-oxide | | CAS: | 1788901-86-9 | | MF: | C21H19ClN4O5 | | MW: | 442.85 | | EINECS: | | | Product Categories: | | | Mol File: | 1788901-86-9.mol |  |
| | Lenvatinib Impurity 5 Chemical Properties |
| density | 1.54±0.1 g/cm3(Predicted) | | storage temp. | -10 to -25°C | | solubility | Methanol (Slightly, Heated) | | pka | 13.10±0.70(Predicted) | | form | Solid | | color | Pale Yellow to Light Yellow | | Major Application | pharmaceutical small molecule |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Repr. 2 STOT RE 2 |
| | Lenvatinib Impurity 5 Usage And Synthesis |
| Uses | Lenvatinib N-Oxide is a metabolite of Lenvatinib (L329400) which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors. |
| | Lenvatinib Impurity 5 Preparation Products And Raw materials |
|